Abstract
Experimental evidence suggests that oxidative stress (OS) may increase the activity of arginine methylating enzymes that produce the endogenous nitric oxide synthase inhibitor asymmetric dimethylarginine (ADMA). In addition, it is well documented that OS can significantly decrease the synthesis and/or activity of ADMA degrading enzymes, thus causing ADMA accumulation in biological fluids. Recent reports have focused on circulating methylated arginine concentrations in chronic obstructive pulmonary disease, a disease characterized by a significant increase in OS. This review discusses the results of these studies and the opportunities for further research in this area.
Similar content being viewed by others
References
Antoniades C, Demosthenous M, Tousoulis D, Antonopoulos AS, Vlachopoulos C, Toutouza M, Marinou K, Bakogiannis C, Mavragani K, Lazaros G, Koumallos N, Triantafyllou C, Lymperiadis D, Koutsilieris M, Stefanadis C (2011) Role of asymmetrical dimethylarginine in inflammation-induced endothelial dysfunction in human atherosclerosis. Hypertension 58(1):93–98
Avci B, Alacam H, Dilek A, Kozan A (2015) Effects of asymmetric dimethylarginine on inflammatory cytokines (TNF-α, IL-6 and IL-10) in rats. Toxicol Ind Health 31(3):268–273
Aydin M, Altintas N, Cem Mutlu L, Bilir B, Oran M, Tülübaş F, Topçu B, Tayfur İ, Küçükyalçin V, Kaplan G, Gürel A (2017) Asymmetric dimethylarginine contributes to airway nitric oxide deficiency in patients with COPD. Clin Respir J 11(3):318–327
Böger RH, Sydow K, Borlak J, Thum T, Lenzen H, Schubert B, Tsikas D, Bode-Böger SM (2000) LDL cholesterol upregulates synthesis of asymmetrical dimethylarginine in human endothelial cells: involvement of S-adenosylmethionine-dependent methyltransferases. Circ Res 87(2):99–105
Böger RH, Maas R, Schulze F, Schwedhelm E (2009) Asymmetric dimethylarginine (ADMA) as a prospective marker of cardiovascular disease and mortality—an update on patient populations with a wide range of cardiovascular risk. Pharmacol Res 60(6):481–487
Chen Y, Xu X, Sheng M, Zhang X, Gu Q, Zheng Z (2009) PRMT-1 and DDAHs-induced ADMA upregulation is involved in ROS- and RAS-mediated diabetic retinopathy. Exp Eye Res 89(6):1028–1034
Costanzo L, Pedone C, Battistoni F, Chiurco D, Santangelo S, Antonelli-Incalzi R (2017) Relationship between FEV1 and arterial stiffness in elderly people with chronic obstructive pulmonary disease. Aging Clin Exp Res 29(2):157–164
Deponte M, Horst Lillig C (2015) Enzymatic control of cysteinyl thiol switches in proteins. Biol Chem 396:401–413
Fan Y, Hu J, Li J, Yang Z, Xin X, Wang J, Ding J, Geng M (2005) Effect of acidic oligosaccharide sugar chain on scopolamine-induced memory impairment in rats and its related mechanisms. Neurosci Lett 374:222–226
Grasemann H, Al-Saleh S, Scott JA, Shehnaz D, Mehl A, Amin R, Rafii M, Pencharz P, Belik J, Ratjen F (2011) Asymmetric dimethylarginine contributes to airway nitric oxide deficiency in patients with cystic fibrosis. Am J Respir Crit Care Med 183(10):1363–1368
Günay E, Sarınç Ulaşlı S, Akar O, Ahsen A, Günay S, Koyuncu T, Unlü M (2014) Neutrophil-to-lymphocyte ratio in chronic obstructive pulmonary disease: a retrospective study. Inflammation 37:374–380
Jiang JL, Zhang XH, Li NS, Rang WQ, Feng-Ye HuCP, Li YJ, Deng HW (2006) Probucol decreases asymmetrical dimethylarginine level by alternation of protein arginine methyltransferase I and dimethylarginine dimethylaminohydrolase activity. Cardiovasc Drugs Ther 20(4):281–294
Kim V, Criner GJ (2013) Chronic bronchitis and chronic obstructive pulmonary disease. Am J Respir Crit Care Med 187:228–237
Kirkham PA, Barnes PJ (2013) Oxidative stress in COPD. Chest 144:266–273
Klein E, Weigel J, Buford MC, Holian A, Wells SM (2010) Asymmetric dimethylarginine potentiates lung inflammation in a mouse model of allergic asthma. Am J Physiol Lung Cell Mol Physiol 299(6):L816–L825
Kurz K, Teerlink T, Sarcletti M, Weiss G, Zangerle R, Fuchs D (2009) Plasma concentrations of the cardiovascular risk factor asymmetric dimethylarginine (ADMA) are increased in patients with HIV-1 infection and correlate with immune activation markers. Pharmacol Res 60(6):508–514
Leiper J, Murray-Rust J, McDonald N, Vallance P (2002) S-nitrosylation of dimethylarginine dimethylaminohydrolase regulates enzyme activity: further interactions between nitric oxide synthase and dimethylarginine dimethylaminohydrolase. Proc Natl Acad Sci USA 99(21):13527–13532
Lv XX, Liu SS, Li K, Cui B, Liu C, Hu ZW (2017) Cigarette smoke promotes COPD by activating platelet-activating factor receptor and inducing neutrophil autophagic death in mice. Oncotarget 8(43):74720–74735
Maarsingh H, Pera T, Meurs H (2008) Arginase and pulmonary diseases. Naunyn Schmiedebergs Arch Pharmacol 378(2):171–184
Montuschi P, Collins JV, Ciabattoni G, Lazzeri N, Corradi M, Kharitonov SA, Barnes PJ (2000) Exhaled 8-isoprostane as an in vivo biomarker of lung oxidative stress in patients with COPD and healthy smokers. Am J Respir Crit Care Med 162:1175–1177
Nemcsik J, Cseprekál O, Egresits J, Kielstein J, Kümpers P, Lukasz A, Tabák Á, Marton A, Németh ZK, Járai Z, Godina G, Sallai L, Farkas K, Kiss I, Tislér A (2017) The role of laser Doppler flowmetry tests, serum angiopoietin-2, asymmetric and symmetric dimethylarginine to predict outcome in chronic kidney disease. J Hypertens 35(5):1109–1118
Numakura T, Sugiura H, Akaike T, Ida T, Fujii S, Koarai A, Yamada M, Onodera K, Hashimoto Y, Tanaka R, Sato K, Shishikura Y, Hirano T, Yanagisawa S, Fujino N, Okazaki T, Tamada T, Hoshikawa Y, Okada Y, Ichinose M (2017) Production of reactive persulfide species in chronic obstructive pulmonary disease. Thorax 72(12):1074–1083
Nural S, Günay E, Halici B, Celik S, Ünlü M (2013) Inflammatory processes and effects of continuous positive airway pressure (CPAP) in overlap syndrome. Inflammation 36(1):66–74
Palm F, Onozato ML, Luo Z, Wilcox CS (2007) Dimethylarginine dimethylaminohydrolase (DDAH): expression, regulation, and function in the cardiovascular and renal systems. Am J Physiol Heart Circ Physiol 293:3227–3245
Pauwels RA, Buist AS, Calverley PM, Jenkins CR, Hurd SS (2001) GOLD Scientific Committee. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. NHLBI/WHO Global Initiative for Chronic Obstructive Lung Disease (GOLD) workshop summary. Am J Respir Crit Care Med 163:1256
Ruzsics I, Nagy L, Keki S, Sarosi V, Illes B, Illes Z, Horvath I, Bogar L, Molnar T (2016) l-Arginine pathway in COPD patients with acute exacerbation: a new potential biomarker. COPD 13(2):139–145
Schwedhelm E, Boger RH (2011) The role of asymmetric and symmetric dimethylarginines in renal disease. Nat Rev Nephrol 7(5):275–285
Scott JA, Grasemann H (2013) Asymmetric dimethylarginine: a disease marker for asthma? Chest 144(2):367–368
Tajti G, Gesztelyi R, Pak K, Papp C, Keki S, Szilasi ME, Mikaczo A, Fodor A, Szilasi M, Zsuga J (2017) Positive correlation of airway resistance and serum asymmetric dimethylarginine level in COPD patients with systemic markers of low-grade inflammation. Int J Chronic Obstr Pulm Dis 12:873–884
Teerlink T (2005) Measurement of asymmetric dimethylarginine in plasma: methodological considerations and clinical relevance. Clin Chem Lab Med 43(10):1130–1138
Telo S, Kırkıl G, Kuluöztürk M, Balin M, Deveci F (2017) Can ADMA play a role in determining pulmonary hypertension related to chronic obstructive pulmonary disease. Clin Respir J. https://doi.org/10.1111/crj.12675
Tran CT, Leiper JM, Vallance P (2003) The DDAH/ADMA/NOS pathway. Atheroscler Suppl 4:33–40
Tyagi N, Sedoris KC, Steed M, Ovechkin AV, Moshal KS, Tyagi SC (2005) Mechanisms of homocysteine-induced oxidative stress. Am J Physiol Heart Circ Physiol 289(6):H2649–H2656
Urban MH, Eickhoff P, Funk GC, Burghuber OC, Wolzt M, Valipour A (2017) Increased brachial intima-media thickness is associated with circulating levels of asymmetric dimethylarginine in patients with COPD. Int J Chronic Obstr Pulm Dis 12:169–176
Vallance P, Leiper J (2004) Cardiovascular biology of the asymmetric dimethylarginine: dimethylarginine dimethylaminohydrolase pathway. Arterioscler Thromb Vasc Biol 24(6):1023–1030
Vestbo J, Hurd SS, Agustí AG, Jones PW, Vogelmeier C, Anzueto A, Barnes PJ, Fabbri LM, Martinez FJ, Nishimura M, Stockley RA, Sin DD, Rodriguez-Roisin R (2013) Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Respir Crit Care Med 187:347–365
Vögeli A, Ottiger M, Meier MA, Steuer C, Bernasconi L, Huber A, Christ-Crain M, Henzen C, Hoess C, Thomann R, Zimmerli W, Mueller B, Schuetz P (2017) Asymmetric dimethylarginine predicts long-term outcome in patients with acute exacerbation of chronic obstructive pulmonary disease. Lung 195(6):717–727
Wells SM, Buford MC, Migliaccio CT, Holian A (2009) Elevated asymmetric dimethylarginine alters lung function and induces collagen deposition in mice. Am J Respir Cell Mol Biol 40(2):179–188
Zinellu A, Fois AG, Sotgia S, Sotgiu E, Zinellu E, Bifulco F, Mangoni AA, Pirina P, Carru C (2016a) Arginines plasma concentration and oxidative stress in mild to moderate COPD. PLoS One 11(8):e0160237
Zinellu E, Zinellu A, Fois AG, Carru C, Pirina P (2016b) Circulating biomarkers of oxidative stress in chronic obstructive pulmonary disease: a systematic review. Respir Res 17(1):150
Acknowledgements
A Visiting Professorship granted to Professor Mangoni by the Department of Biomedical Sciences, University of Sassari (Italy), facilitated this work.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest.
Research involving human participants and/or animals
Not applicable.
Informed consent
Not applicable.
Additional information
Handling Editor: J. D. Wade.
Rights and permissions
About this article
Cite this article
Zinellu, A., Fois, A.G., Mangoni, A.A. et al. Systemic concentrations of asymmetric dimethylarginine (ADMA) in chronic obstructive pulmonary disease (COPD): state of the art. Amino Acids 50, 1169–1176 (2018). https://doi.org/10.1007/s00726-018-2606-7
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00726-018-2606-7